Pain Management News

There are two FDA-approved medications for PTSD, both selective serotonin reuptake inhibitors. The FDA has not approved a new medication for PTSD since 2001.

The FDA on Aug. 9 issued a complete response letter to Lycos Therapeutics for its new drug application regarding midomafetamine capsules for the treatment of PTSD, citing insufficient data to approve and requesting an additional phase 3 trial.

Patients with breast cancer who reported high burdens of pain and stress had poorer outcomes than those with lower pain or stress levels, according to research presented at ASCO Annual Meeting.

Acupuncture was superior to sham acupuncture in reducing methadone doses and opioid cravings in patients undergoing treatment for opioid addiction, findings showed.

Few individuals received medications for opioid use disorder or filled a naloxone prescription after a nonfatal drug overdose, despite the benefits of these treatments in reducing the odds for a future fatal overdose, data show.

Healio has launched a new special report on medical cannabis that summarizes the current scientific research and incorporates expert opinion.

NEW YORK — In this Healio Video Perspective from the American Psychiatric Association annual meeting, Candace Hatten-Powell, MD, talks about opioid-sparing medications that may be used following bariatric surgery.

As healers, we are most comfortable and confident when we can rely on the long-established armamentarium of countless medications created by the American pharmaceutical industry.

Healio is accepting submissions for its third annual peer-recognition program, Healio Honors.